Finding diabetes and prediabetes markers in blood and urine
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at leftover blood and urine samples to find new markers that could help detect prediabetes and diabetes earlier. It may lead to better testing and management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with prediabetes, diabetes, or gestational diabetes, or a healthy control.
- You have leftover fasting blood and urine samples from a recent glucose test.
- Your sample must be at least 300 microliters and stored properly without being frozen and thawed many times.
- Your blood sample should not be visibly broken down (hemolyzed), fatty (lipemic), or jaundiced.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for people who are at high risk of developing prediabetes (but don't have it yet) and tests whether early monitoring with a continuous glucose monitor can help prevent it. It's a good fit if you're 35 or older with a high diabetes risk score but normal blood sugar levels.
This study tests whether a continuous glucose monitor (CGM) can help people with prediabetes track their blood sugar levels over 20 days. You may be eligible if you have prediabetes, a BMI of 25 or higher, and a compatible smartphone.
This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.
This study tests whether a Mediterranean diet can help people with prediabetes improve their blood sugar levels. You'll follow a specific meal plan for a period of time and have your blood sugar and other health markers checked.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.